The Fourth Trimester: Pregnancy as a Predictor of Cardiovascular Disease

Pensée Wu1, Ki Park2, Martha Gulati3

  • 1School of Medicine, Keele University Staffordshire, UK.

European Cardiology
|October 4, 2021
PubMed

Insights

Adverse pregnancy outcomes (APOs) signal increased cardiovascular disease (CVD) risk in women. Early atherosclerotic CVD (ASCVD) risk assessment and intervention are crucial for women with APO history.

Area of Science:

  • Cardiovascular Medicine
  • Obstetrics & Gynecology
  • Public Health

Background:

  • Adverse pregnancy outcomes (APOs) are linked to increased cardiovascular disease (CVD) risk in women.
  • The shared pathogenesis of various APOs suggests a common pathway contributing to later CVD.
  • Current CVD risk assessment in women, particularly young women, often underestimates risk.

Purpose of the Study:

  • To explore the role of APOs in identifying women at higher risk for future CVD.
  • To investigate the potential benefits of atherosclerotic CVD (ASCVD) risk reduction strategies in women with APO history.
  • To highlight the need for improved CVD risk assessment and management in women with APOs.

Main Methods:

  • This study reviews existing literature and clinical data on the association between APOs and CVD.
  • It examines the underlying mechanisms potentially linking APOs to cardiovascular pathology.
  • The research analyzes current guidelines for CVD risk assessment in women and identifies gaps.

Main Results:

  • APOs serve as an indicator for increased long-term CVD risk.
  • The precise relationship between APOs and CVD (causal vs. uncovering predisposition) requires further investigation.
  • Aggressive ASCVD risk modification strategies may benefit women with a history of APOs.

Conclusions:

  • Women experiencing APOs require vigilant cardiovascular monitoring and risk stratification.
  • Further research is essential to refine ASCVD risk assessment tools and interventions for this population.
  • Early identification and management of CVD risk factors post-APO are critical for maternal health.

Related Concept Videos

Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
60
Imaging Studies for Cardiovascular System III: X-Ray01:20

Imaging Studies for Cardiovascular System III: X-Ray

The most common cardiovascular diagnostic test is an X-ray. It produces images of the heart, blood vessels, and adjacent structures.
Definition and Purpose
An X-ray, or radiograph, is a non-invasive method that uses ionizing radiation to take images of internal structures. It is mainly used in cardiac imaging to examine the heart, lungs, and major blood vessels, aiming to identify abnormalities in the heart's size, shape, and position, such as heart failure, congenital defects, and vascular...
321
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
401
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
111
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
265
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
418